• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活体肝移植供体不良结局的发生率:60829 例供体的荟萃分析。

The incidence of adverse outcome in donors after living donor liver transplantation: A meta-analysis of 60,829 donors.

机构信息

Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Biostatistics & Modelling Domain, Saw Swee Hock School of Public Health, National University of Singapore, Singapore.

出版信息

Liver Transpl. 2024 May 1;30(5):493-504. doi: 10.1097/LVT.0000000000000303. Epub 2023 Nov 29.

DOI:10.1097/LVT.0000000000000303
PMID:38015449
Abstract

The scarcity of liver grafts has prompted developments in living donor liver transplantations (LDLT), with previous literature illustrating similar outcomes in recipients compared to deceased donor transplants. However, significant concerns regarding living donor morbidity and mortality have yet to be examined comprehensively. This study aims to provide estimates of the incidence of various outcomes in living liver donors. In this meta-analysis, Medline and Embase were searched from inception to July 2022 for articles assessing the incidence of outcomes in LDLT donors. Complications in the included studies were classified into respective organ systems. Analysis of incidence was conducted using a generalized linear mixed model with Clopper-Pearson intervals. Eighty-seven articles involving 60,829 living liver donors were included. The overall pooled incidence of complications in LDLT donors was 24.7% (CI: 21.6%-28.1%). The incidence of minor complications was 17.3% (CI: 14.7%-20.3%), while the incidence of major complications was lower at 5.5% (CI: 4.5%-6.7%). The overall incidence of donor mortality was 0.06% (CI: 0.0%-0.1%) in 49,027 individuals. Psychological complications (7.6%, CI: 4.9%-11.5%) were the most common among LDLT donors, followed by wound-related (5.2%, CI: 4.4%-6.2%) and respiratory complications (4.9%, CI: 3.8%-6.3%). Conversely, cardiovascular complications had the lowest incidence among the subgroups at 0.8% (CI: 0.4%-1.3%). This study presents the incidence of post-LDLT outcomes in living liver donors, illustrating significant psychological, wound-related, and respiratory complications. While significant advancements in recent decades have contributed towards decreased morbidity in living donors, our findings call for targeted measures and continued efforts to ensure the safety and quality of life of liver donors post-LDLT.

摘要

供肝短缺促使人们开展活体肝移植(LDLT),既往文献表明,与尸体供肝移植相比,LDLT 受者的结局相似。然而,活体供者发病率和死亡率方面的一些重大问题尚未得到全面研究。本研究旨在评估活体肝供者各种结局的发生率。本荟萃分析检索了从建库至 2022 年 7 月的 Medline 和 Embase 数据库,以评估 LDLT 供者结局发生率的文章。将纳入研究中的并发症分为相应的器官系统。采用广义线性混合模型和 Clopper-Pearson 区间进行发生率分析。共纳入 87 篇涉及 60829 例活体肝供者的文章。LDLT 供者的总体并发症发生率为 24.7%(95%CI:21.6%-28.1%)。轻微并发症发生率为 17.3%(95%CI:14.7%-20.3%),而严重并发症发生率较低,为 5.5%(95%CI:4.5%-6.7%)。49027 例供者的总死亡率为 0.06%(95%CI:0.0%-0.1%)。LDLT 供者中最常见的心理并发症为 7.6%(95%CI:4.9%-11.5%),其次为与伤口相关的并发症(5.2%,95%CI:4.4%-6.2%)和呼吸系统并发症(4.9%,95%CI:3.8%-6.3%)。相反,心血管并发症的发生率在亚组中最低,为 0.8%(95%CI:0.4%-1.3%)。本研究报告了活体肝移植后供者结局的发生率,表明存在显著的心理、与伤口相关和呼吸系统并发症。尽管近几十年来取得了显著进展,降低了活体供者的发病率,但我们的研究结果表明,需要采取有针对性的措施并持续努力,以确保 LDLT 后肝供者的安全和生活质量。

相似文献

1
The incidence of adverse outcome in donors after living donor liver transplantation: A meta-analysis of 60,829 donors.活体肝移植供体不良结局的发生率:60829 例供体的荟萃分析。
Liver Transpl. 2024 May 1;30(5):493-504. doi: 10.1097/LVT.0000000000000303. Epub 2023 Nov 29.
2
Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.在一个器官严重短缺的地区,对于模型预测终末期肝病评分(MELD)超过 30 的患者,活体肝移植的生存获益:一项回顾性队列研究。
Int J Surg. 2023 Nov 1;109(11):3459-3466. doi: 10.1097/JS9.0000000000000634.
3
Clinical outcomes after ABO-incompatible liver transplantation: A systematic review and meta-analysis.ABO 不相容肝移植后的临床结局:系统评价和荟萃分析。
Transpl Immunol. 2021 Dec;69:101476. doi: 10.1016/j.trim.2021.101476. Epub 2021 Oct 1.
4
Does modification of portal pressure and flow enhance recovery of the recipient after living donor liver transplantation? A systematic review of literature and expert panel recommendations.门静脉压力和血流的改变能否提高活体肝移植受者的恢复情况?一项文献系统综述及专家小组建议。
Clin Transplant. 2022 Oct;36(10):e14657. doi: 10.1111/ctr.14657.
5
Can living donor liver transplantation provide similar outcomes to deceased-donor liver transplantation for hepatocellular carcinoma? A systematic review and meta-analysis.活体供肝移植能否为肝细胞癌提供与死体供肝移植相似的结果?系统评价和荟萃分析。
Hepatol Int. 2023 Feb;17(1):18-37. doi: 10.1007/s12072-022-10435-3. Epub 2022 Dec 23.
6
Comparisons of liver transplant from DCD outcomes in high-utilization centers versus low-utilization centers in the US: a systematic review and meta-analysis.美国高利用率中心与低利用率中心DCD肝移植结局的比较:一项系统评价和荟萃分析。
Front Immunol. 2025 May 9;16:1564551. doi: 10.3389/fimmu.2025.1564551. eCollection 2025.
7
Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.成人活体供肝肝移植和尸体供肝肝移植的手术结果:一项系统评价和荟萃分析。
Liver Transpl. 2014 Apr;20(4):425-36. doi: 10.1002/lt.23836.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Pediatric living donor liver transplantation for small infants with biliary atresia using interposition portal vein grafts: A multicenter cohort study.使用门静脉间置移植物对小婴儿胆道闭锁进行小儿活体肝移植:一项多中心队列研究。
Liver Transpl. 2025 Jul 1;31(7):890-896. doi: 10.1097/LVT.0000000000000596. Epub 2025 Mar 13.
10
Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.成人血液系统恶性肿瘤的骨髓与外周血异基因造血干细胞移植
Cochrane Database Syst Rev. 2014 Apr 20;2014(4):CD010189. doi: 10.1002/14651858.CD010189.pub2.

引用本文的文献

1
Living-Donor Liver Transplantation-The Need for Greater Transparency.活体肝移植——更高透明度的必要性
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102507. doi: 10.1016/j.jceh.2025.102507. Epub 2025 Jan 21.
2
Chinese guidelines for minimally invasive donor hepatectomy in living donor liver transplantation (2024 edition).《中国活体肝移植供体微创肝切除术指南(2024年版)》
Hepatobiliary Surg Nutr. 2024 Dec 1;13(6):919-936. doi: 10.21037/hbsn-24-329. Epub 2024 Nov 20.
3
Donors' Outcome After Living Donor Liver Transplantation in a University Teaching Hospital: A Case Series.
大学教学医院活体肝移植供体的结局:病例系列
Cureus. 2024 Oct 19;16(10):e71858. doi: 10.7759/cureus.71858. eCollection 2024 Oct.
4
Impact of Baseline Anti-ABO Antibody Titer on Biliary Complications in ABO-Incompatible Living-Donor Liver Transplantation.基线抗ABO抗体滴度对ABO血型不相容活体肝移植中胆道并发症的影响。
J Clin Med. 2024 Aug 14;13(16):4789. doi: 10.3390/jcm13164789.
5
Implementation of a living donor liver transplantation program in the Republic of Uzbekistan: a report of the first 40 cases.乌兹别克斯坦共和国活体肝移植项目的实施:前40例报告。
Clin Transplant Res. 2024 Jun 30;38(2):116-127. doi: 10.4285/ctr.24.0013. Epub 2024 Jun 24.